Tokyo, July 12 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062213) titled 'Evaluation of the clinical usability of a novel guidewire fixation device in percutaneous catheter treatment' on July 12.
Study Type:
Interventional
Study Design:
Basic Design - n-of-1
Randomization - Non-randomized
Blinding - Open -but assessor(s) are blinded
Control - Uncontrolled
Primary Sponsor:
Institute - Mie University Hospital
Condition:
Condition - 30 cases using a new guidewire fixation device
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - We
Basic objectives2 - Safety
Intervention:
Interventions/Control_1 - Survey
Eligibility:
Age-lower limit - 20
years-old
Gender - Male and Female
Key inclusion criteria - 1) Be a practitioner who will actually use the novel guidewire fixation device being evaluated in this study.
2) Be able to complete the questionnaire administered after using the device.
3) Have provided written informed consent.
Key exclusion criteria - If you meet any of the following criteria, you are not eligible to participate in this study.
1) If the researcher determines that your participation in this study is inappropriate.
Target Size - 30
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 07 Month 11 Day
Anticipated trial start date - 2026 Year 07 Month 11 Day
Last follow-up date - 2027 Year 12 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071196
Disclaimer: Curated by HT Syndication.
